David April wrote -
Since I ran the Love Run last year, I was diagnosed with a lesion on my pancreas in addition to the metastasis in my lungs diagnosed in 2018. I’ve been in a clinical trial since August and am responding well to the treatments. The first CT scan from the trial revealed that the treatments are working and the situation is under control! And while I am not cancer-free, my body is responding well to the drugs.
In the trial, I’m benefiting from the latest breakthroughs in immunotherapy and targeted therapy. Traditional chemotherapy is not effective against kidney cancer and these new types of drugs are game-changers in treating renal cell carcinoma. My treatment consists of monthly infusions of an immunotherapy drug and twice-daily doses of an oral targeted inhibitor. The immunotherapy stimulates my immune system to attack the cancer, and the targeted inhibitor blocks cancer cells from receiving oxygen. Both trial drugs are already FDA approved, however, researchers are testing this particular combination. I will continue in the trial and hope that the cancer will be managed for many years.
The side effects are manageable and don’t significantly impact my quality of life. I’ve not been able to run as before but still enjoy getting out there to run and walk. My goal is to run the Love Run surrounded by my family and friends.
Thank you to Carmen who has been with me every step of the way, and my sisters for their love and support. I have the best friends in the world and an incredible running community that have encouraged me. I especially want to thank the doctors, staff and support teams at the Sidney Kimmel Cancer Center - Jefferson Health and the Fox Chase Cancer Center. Philadelphia is truly fortunate to have these and other world-class cancer centers.
I hope you will consider making a donation to Legacy of Hope and give hope to other patients like me.